Viewing data from:

HALOPERIDOL DECANOATE

ANDA

HALOPERIDOL DECANOATE | A074893 | FRESENIUS KABI USA LLC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$17.40

per ml

Lowest NADAC/Unit

$13.18

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
63323047141HALOPERIDOL DEC 100 MG/ML VIAL	$17.40	ML	Generic	—	2026-06-17
63323047101HALOPERIDOL DEC 100 MG/ML VIAL	$17.40	ML	Generic	—	2026-06-17
63323047105HALOPERIDOL DEC 500 MG/5 ML VL	$13.18	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$18.44

Highest Price

$150.75

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
63323-0469-01HALOPERIDOL DECANOTE 50MG/ML INJ	$18.44	FSS	Fresenius Kabi, LLC	05/14/2030
63323-0469-05HALOPERIDOL DECANOTE 250MG/5ML INJ	$109.08	FSS	Fresenius Kabi, LLC	05/14/2030
63323-0471-01HALOPERIDOL DECANOTE 100MG/ML INJ	$29.60	FSS	Fresenius Kabi, LLC	05/14/2030
63323-0471-05HALOPERIDOL DECANOTE 500MG/5ML INJ	$150.75	FSS	Fresenius Kabi, LLC	05/14/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs2 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

JANSSEN PHARMACEUTICA NVHALOPERIDOL DECANOATE

DMF 109541994

TAPI NL BVHALOPERIDOL DECANOATE

DMF 125301997

OLON SPAHALOPERIDOL DECANOATE

DMF 169492003

MSN LIFE SCIENCES PRIVATE LTDHALOPERIDOL DECANOATE USP

DMF 337032019

MANKIND PHARMA LTDHALOPERIDOL DECANOATE USP

DMF 343532020

PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANAInactiveHALOPERIDOL DECANOATE

DMF 66821986

EXCELLA GMBHInactiveHALOPERIDOL DECANOATE

DMF 191972006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 50MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Dec 19, 1997

No patent or exclusivity listings for this strength.

#002 — EQ 100MG BASE/ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Dec 19, 1997